Natalia Shcherbakova to United States
This is a "connection" page, showing publications Natalia Shcherbakova has written about United States.
Connection Strength
0.434
-
Shcherbakova N, Pesaturo KA, Pezzuto JM. High Total Failures of the North American Pharmacist Licensure Examination (NAPLEX) Warrant Monitoring of Professional Pharmacy Programs. Am J Pharm Educ. 2024 Jul; 88(7):100723.
Score: 0.088
-
Qasba NT, Wallace KF, Yu V, Capoccia KL, Goff SL, Shcherbakova N. Online survey of consumer awareness and perceptions of a Massachusetts law for 12-month supply of contraception. Contraception. 2023 12; 128:110138.
Score: 0.083
-
Shcherbakova N, Desselle S. Looking Back at US Pharmacy's Past to Help Discern Its Future. Ann Pharmacother. 2020 09; 54(9):907-920.
Score: 0.065
-
Shcherbakova N, Tereso G, Spain J, Roose RJ. Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder. Ann Pharmacother. 2018 05; 52(5):405-414.
Score: 0.056
-
Shcherbakova N, Tereso G. Clinical pharmacist home visits and 30-day readmissions in Medicare Advantage beneficiaries. J Eval Clin Pract. 2016 Jun; 22(3):363-8.
Score: 0.049
-
Shcherbakova N. The delivery mode matters when surveying U.S. practicing pharmacists: The reason to say 'no' to the hybrid method. Res Social Adm Pharm. 2016 Jan-Feb; 12(1):169-170.
Score: 0.048
-
Shcherbakova N, Rascati K, Brown C, Lawson K, Novak S, Richards KM, Yoder L. Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims. CNS Drugs. 2014 Nov; 28(11):1047-58.
Score: 0.045